tiprankstipranks
Trending News
More News >
Psyence Group (TSE:PSYG)
:PSYG
Advertisement

Psyence Group (PSYG) Price & Analysis

Compare
6 Followers

PSYG Stock Chart & Stats

C$0.12
>-C$0.01(-33.33%)
At close: 4:00 PM EST
C$0.12
>-C$0.01(-33.33%)

Psyence Group News

PSYG FAQ

What was Psyence Group’s price range in the past 12 months?
Psyence Group lowest stock price was C$0.10 and its highest was C$0.30 in the past 12 months.
    What is Psyence Group’s market cap?
    Psyence Group’s market cap is C$1.88M.
      When is Psyence Group’s upcoming earnings report date?
      Psyence Group’s upcoming earnings report date is Mar 04, 2026 which is in 86 days.
        How were Psyence Group’s earnings last quarter?
        Psyence Group released its earnings results on Nov 28, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
          Is Psyence Group overvalued?
          According to Wall Street analysts Psyence Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Psyence Group pay dividends?
            Psyence Group does not currently pay dividends.
            What is Psyence Group’s EPS estimate?
            Psyence Group’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Psyence Group have?
            Psyence Group has 15,638,267 shares outstanding.
              What happened to Psyence Group’s price movement after its last earnings report?
              Psyence Group reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Psyence Group?
                Currently, no hedge funds are holding shares in TSE:PSYG

                Company Description

                Psyence Group

                Psyence Group (PSYG) is a biotechnology company focused on advancing psychedelic therapy and natural-based medicine. The company operates in the life sciences sector, leveraging the therapeutic potential of psychedelic compounds to address mental health issues and neurological disorders. Psyence’s core products and services include the development of natural psilocybin-based therapies, cultivating and processing psilocybin mushrooms, and conducting clinical trials to establish the efficacy and safety of their treatments.

                Psyence Group (PSYG) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Braxia Scientific
                New Leaf Ventures
                Entheon Biomedical
                Silo Wellness Inc
                Revitalist Lifestyle & Wellness Ltd

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis